What is the address of VERELST-RNA?

The registered office of VERELST-RNA is located at Klein Boom 15, 2580 Putte.

Is VERELST-RNA still active?

Yes. According to the CBE (29 October 2026) VERELST-RNA is active, legal situation “Normale toestand”, started on 18 October 2018.

Is VERELST-RNA registered on Peppol?

Yes, VERELST-RNA is registered on the Peppol network with ID 0208:0711843903.

What is the enterprise number of VERELST-RNA?

The enterprise number of VERELST-RNA is BE0711843903.

When was VERELST-RNA founded?

VERELST-RNA was founded on 18 October 2018.

Who are the directors of VERELST-RNA?

According to the 2024 annual accounts, the directors of VERELST-RNA are: QUATOR CORONATI GEENS BV, VERBOCON BV, RC CONSTRUCT BV.

Is VERELST-RNA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 October 2018; 4 annual accounts filed, latest fiscal year 2024; 3 directors known from the annual account.

How much profit did VERELST-RNA make in 2024?

VERELST-RNA posted a profit after taxes of € 310,625 in financial year 2024.

What is the revenue of VERELST-RNA?

In its most recent annual accounts (2024), VERELST-RNA reported revenue of € 600,000.

VERELST-RNA (Private Limited) - Putte - BE0711843903

Q: What does VERELST-RNA do?

VERELST-RNA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 18 October 2018, 1 establishment.

Dossier VERELST-RNA, printed on 29 October 2026 from databakkes.be/en/0711843903/verelst-rna. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

17 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2024

VERELST-RNA from Putte, company number BE0711843903, closed financial year 2024 with a result of € 310,625 after tax. For that financial year VERELST-RNA recorded revenue of € 600,000 and equity of € 410,135. Compared with financial year 2023, the result moved from € 53,505 to € 310,625. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 18, 2025.

What it is worth Growing

€ 410,135

▲ € 310,625 vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 310,625

▲ € 257,120 vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 19,549

▲ € 19,273 vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 344,135.

Debts at end 2024

Bank debt

€ 450,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 43,733

▲ 13% vs 2023

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 107 days on average.

Taxes

€ 70,706

▲ 279% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 160,000 Revenue 2021: € 160,000 First fiscal year in the series	€ 160,000 Revenue 2022: € 160,000 Unchanged (€ 160,000) Unchanged	€ 255,000 Revenue 2023: € 255,000 ▲ 59% vs 2022 (€ 160,000) Favourable step	€ 600,000 Revenue 2024: € 600,000 ▲ 135% vs 2023 (€ 255,000) Favourable step	▲ 135%
Profit after taxes	€ -10,521 Profit after taxes 2021: € -10,521 First fiscal year in the series	€ -11,509 Profit after taxes 2022: € -11,509 ▼ € 988 vs 2021 (€ -10,521) Unfavourable step	€ 53,505 Profit after taxes 2023: € 53,505 ▲ € 65,014 vs 2022 (€ -11,509) Favourable step	€ 310,625 Profit after taxes 2024: € 310,625 ▲ € 257,120 vs 2023 (€ 53,505) Favourable step	▲ € 257,120
Equity	€ 57,514 Equity 2021: € 57,514 First fiscal year in the series	€ 46,005 Equity 2022: € 46,005 ▼ 20% vs 2021 (€ 57,514) Unfavourable step	€ 99,510 Equity 2023: € 99,510 ▲ 116% vs 2022 (€ 46,005) Favourable step	€ 410,135 Equity 2024: € 410,135 ▲ € 310,625 vs 2023 (€ 99,510) Favourable step	▲ € 310,625
Total debts	€ 630,025 Total debts 2021: € 630,025 First fiscal year in the series	€ 621,742 Total debts 2022: € 621,742 ▼ 1% vs 2021 (€ 630,025) Favourable step	€ 1,030,859 Total debts 2023: € 1,030,859 ▲ 66% vs 2022 (€ 621,742) Unfavourable step	€ 896,163 Total debts 2024: € 896,163 ▼ 13% vs 2023 (€ 1,030,859) Favourable step	▼ 13%
Cash	€ 6,436 Cash 2021: € 6,436 First fiscal year in the series	€ 3,481 Cash 2022: € 3,481 ▼ 46% vs 2021 (€ 6,436) Unfavourable step	€ 276 Cash 2023: € 276 ▼ 92% vs 2022 (€ 3,481) Unfavourable step	€ 19,549 Cash 2024: € 19,549 ▲ € 19,273 vs 2023 (€ 276) Favourable step	▲ € 19,273
Retained profit	€ -8,486 Retained profit 2021: € -8,486 First fiscal year in the series	€ -19,995 Retained profit 2022: € -19,995 ▼ € 11,509 vs 2021 (€ -8,486) Unfavourable step	€ 33,510 Retained profit 2023: € 33,510 ▲ € 53,505 vs 2022 (€ -19,995) Favourable step	€ 344,135 Retained profit 2024: € 344,135 ▲ € 310,625 vs 2023 (€ 33,510) Favourable step	▲ € 310,625
Bank debt	€ 575,000 Bank debt 2021: € 575,000 First fiscal year in the series	€ 575,000 Bank debt 2022: € 575,000 Unchanged (€ 575,000) Unchanged	€ 450,000 Bank debt 2023: € 450,000 ▼ 22% vs 2022 (€ 575,000) Favourable step	€ 450,000 Bank debt 2024: € 450,000 Unchanged (€ 450,000) Unchanged
Balance sheet total	€ 687,539 Balance sheet total 2021: € 687,539 First fiscal year in the series	€ 667,747 Balance sheet total 2022: € 667,747 ▼ 3% vs 2021 (€ 687,539) Unchanged	€ 1,130,368 Balance sheet total 2023: € 1,130,368 ▲ 69% vs 2022 (€ 667,747) Unchanged	€ 1,306,298 Balance sheet total 2024: € 1,306,298 ▲ 16% vs 2023 (€ 1,130,368) Unchanged	▲ 16%

Key figures of VERELST-RNA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to VERELST-RNA?

What happened at VERELST-RNA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 18, 2025 New annual accounts for financial year 2024: profit of € 310,625 (▲ € 257,120 vs 2023). filed late Source: NBB ↗
2023 QUATOR CORONATI GEENS BV became a director. NBB
2023 VERBOCON BV became a director. NBB
2023 RC CONSTRUCT BV became a director. NBB
Oct 18, 2018 New establishment in Putte. KBO
Oct 18, 2018 Start of the company according to the CBE. KBO

In short

From € 10,521 loss in 2021 to € 310,625 profit in 2024.

Paid € 120,000 in corporate taxes since 2021.

Best year ever: 2024, with € 310,625 profit.

Pays suppliers within 107 days on average.

Original PDFs at the National Bank ↗

Management

Verbocon 33.3%

The stake of Verbocon comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VERELST-RNA

VERELST ONTWIKKELINGSGROEP 99.8%

VERGECO

ZOLAR

PEIROUN

Behind VERELST-RNA are QUATOR CORONATI GEENS BV, VERBOCON BV and RC CONSTRUCT BV. The shares are held by Verbocon (33.3%). It owns 99.8% of VERELST ONTWIKKELINGSGROEP, VERGECO, ZOLAR, PEIROUN and CHALAIN itself.